TrialThe AAPS journal2026

Population Pharmacokinetics and Exposure-response Analysis of Durvalumab in Patients with Limited-stage Small-cell Lung Cancer in the Phase 3 ADRIATIC Study.

Hong Su et al.PubMed ↗Publisher ↗

No numbers read from the abstract.